Hemostemix Inc's stock has seen a notable decline this week, reflecting broader market trends in the health care sector.
As of the latest trading session, Hemostemix Inc (HEM.V) closed at C$0.06, remaining unchanged for the day but down 7.69% over the past week. Investors are closely watching the stock due to its recent performance and the absence of significant news.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$12.69M
52W high
$0.13
52W low
$0.04
1W change
-7.69%
Beta
0.67
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1500.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1500.0% Upside
Current Price
C$0.06
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
80.9%
Annualized
90-Day Vol
110.8%
Annualized
Trend (90d)
+36.5%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.05 – C$0.08 |
| 60 trading days | C$0.07 | C$0.04 – C$0.10 |
| 90 trading days | C$0.07 | C$0.04 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Hemostemix has not released any recent updates, its performance metrics suggest that a cautious approach may be wise given the declining price trends and low trading volume.
HEM.V's stock is down 7.69% this week.
The stock has a 52-week range of C$0.04 to C$0.13, currently trading at 24% of this range, indicating significant volatility and investor uncertainty.
Bull case
Analysts are optimistic about Hemostemix, with an average target price of C$0.96. This suggests a potential upside of 1500% from the current price, driven by the company's growth prospects in the health care sector.
Bear case
However, the stock has faced challenges this year, down 33.33% year-to-date. Its recent trading volume is well below the 20-day average, signaling a lack of investor interest and possible concerns about its financial health.
Recent Price Action
Advertisement
Hemostemix Inc (HEM.V) has closed at C$0.06, showing no change for the day. However, the stock has experienced a decline of 7.69% over the past week and is down 14.29% over the last month. Year-to-date performance reflects a significant drop of 33.33%, suggesting a challenging environment for the company.
Technical Picture
Looking at the technical indicators, HEM.V is currently trading below both its 50-day and 200-day moving averages, which stand at C$0.07. The stock is trading at 12.8% below the 50-day MA and 15.8% below the 200-day MA. The 52-week range of C$0.04 to C$0.13 indicates that the stock is currently at 24% of its range. With a beta of 0.67, HEM.V shows lower volatility compared to the broader market.
Volume Analysis
The latest trading session saw a volume of 5,000 shares, significantly lower than the 20-day average volume of 24,730 shares, resulting in a volume ratio of 0.20x. This low trading volume may indicate reduced investor interest or caution among traders regarding the stock's future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
